Trabectedin: A Review of its Use in Soft Tissue Sarcoma and Ovarian Cancer

ISSN： 0012-6667

Source： Drugs, Vol.70, Iss.3, 2010-02, pp. : 335-376

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Trabectedin: A Review of its Use in the Management of Soft Tissue Sarcoma and Ovarian Cancer

By Carter Natalie J. Keam Susan J.

Drugs, Vol. 67, Iss. 15, 2007-01 ,pp. : 2257-2276

Adis International

Access to resources Recommend Favorite

Pegylated Liposomal Doxorubicin: A Review of its use in Metastatic Breast Cancer, Ovarian Cancer, Multiple Myeloma and AIDS-Related Kaposi's Sarcoma

By Duggan Sean T. Keating Gillian M.

Drugs, Vol. 71, Iss. 18, 2011-12 ,pp. : 2531-2558

Adis International

Access to resources Recommend Favorite

Trabectedin in pre-treated patients with advanced or metastatic soft tissue sarcoma: a phase II study evaluating co-treatment with dexamethasone

By Paz-Ares Luis

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 729-740

Springer Publishing Company

Access to resources Recommend Favorite

Safety evaluation of trabectedin in treatment of soft-tissue sarcomas

By Martin-Liberal Juan Judson Ian

Expert Opinion on Drug Safety, Vol. 12, Iss. 6, 2013-11 ,pp. : 905-911

Informa Healthcare

Access to resources Recommend Favorite

Pathology of Soft Tissue Sarcoma

By Rubin Brian P. Goldblum John R.

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 5, Iss. 4, 2007-04 ,pp. : 411-418

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite